These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 38688967)

  • 1. Combined pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio predicts survival and prognosis in patients with non-metastatic nasopharyngeal carcinoma: a retrospective study.
    Yang D; Li P; Meng Z; Hu X; Huang Z; Huang H; Dong H; Qin Y; Chen C; Chen X; Li Z; Zhou Z; Li Y; Kang M
    Sci Rep; 2024 Apr; 14(1):9898. PubMed ID: 38688967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of EBV DNA and platelet-to-lymphocyte ratio in patients with non-metastatic nasopharyngeal carcinoma: a retrospective study.
    Dong H; Huang Z; Yang D; Li Z; Huang H; Meng Z; Qin Y; Kang M
    BMC Cancer; 2023 Jul; 23(1):673. PubMed ID: 37464319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic value of the ratio of neutrophils to lymphocytes before and after intensity modulated radiotherapy for patients with nasopharyngeal carcinoma.
    Liu J; Wei C; Tang H; Liu Y; Liu W; Lin C
    Medicine (Baltimore); 2020 Jan; 99(2):e18545. PubMed ID: 31914029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective study of a novel hematological parameter for predicting the survival of patients with nasopharyngeal carcinoma.
    Tang W; Long G
    PeerJ; 2024; 12():e17573. PubMed ID: 38915379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel Inflammation-Based Stage (I Stage) Predicts Overall Survival of Patients with Nasopharyngeal Carcinoma.
    Li JP; Chen SL; Liu XM; He X; Xing S; Liu YJ; Lin YH; Liu WL
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27854304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Significance of Neutrophil to Lymphocyte Ratio, Lymphocyte to Monocyte Ratio, and Platelet to Lymphocyte Ratio in Patients with Nasopharyngeal Carcinoma.
    Lu A; Li H; Zheng Y; Tang M; Li J; Wu H; Zhong W; Gao J; Ou N; Cai Y
    Biomed Res Int; 2017; 2017():3047802. PubMed ID: 28321405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil-to-lymphocyte ratio and monocyte-to-eosinophil ratio as prognostic indicators for advanced nasopharyngeal carcinoma.
    Ye M; Huang A; Yuan B; Tan G; Ai J; Liu H
    Eur Arch Otorhinolaryngol; 2024 Apr; 281(4):1971-1989. PubMed ID: 38315178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High Expression of NLR and SII in patients With Nasopharyngeal Carcinoma as Potential Prognostic Observations.
    Lv H; Chen X; Chen X; Li J; Lu X
    Cancer Control; 2024; 31():10732748241288106. PubMed ID: 39323032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic values of hematological biomarkers in nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy.
    Ye L; Oei RW; Kong F; Xu T; Shen C; Wang X; He X; Kong L; Hu C; Ying H
    Eur Arch Otorhinolaryngol; 2018 May; 275(5):1309-1317. PubMed ID: 29589142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of immune inflammation-based index for predicting the clinical outcome in patients with nasopharyngeal carcinoma.
    Zeng X; Liu G; Pan Y; Li Y
    J Cell Mol Med; 2020 Aug; 24(15):8326-8349. PubMed ID: 32603520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triglyceride-inflammation score established on account of random survival forest for predicting survival in patients with nasopharyngeal carcinoma: a retrospective study.
    Li J; Ye Y; Cai Y; Ji H; Qin W; Luo Y; Zhou X; Zhang Z; Xiao X; Zhang B
    Front Immunol; 2024; 15():1375931. PubMed ID: 38736892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio, and Platelets in the Prognosis of Metastatic Renal Cell Carcinoma.
    Huszno J; Kolosza Z; Mrochem-Kwarciak J; Rutkowski T; Skladowski K
    Oncology; 2019; 97(1):7-17. PubMed ID: 31048577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The elevated pretreatment platelet-to-lymphocyte ratio predicts poor outcome in nasopharyngeal carcinoma patients.
    Jiang R; Zou X; Hu W; Fan YY; Yan Y; Zhang MX; You R; Sun R; Luo DH; Chen QY; Huang PY; Hua YJ; Guo L; Chen MY
    Tumour Biol; 2015 Sep; 36(10):7775-87. PubMed ID: 25944165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Glasgow Prognostic Score predicts poor survival in cisplatin-based treated patients with metastatic nasopharyngeal carcinoma.
    Chen C; Sun P; Dai QS; Weng HW; Li HP; Ye S
    PLoS One; 2014; 9(11):e112581. PubMed ID: 25393117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete Blood Count Score Model Integrating Reduced Lymphocyte-Monocyte Ratio, Elevated Neutrophil-Lymphocyte Ratio, and Elevated Platelet-Lymphocyte Ratio Predicts Inferior Clinical Outcomes in Adult T-Lymphoblastic Lymphoma.
    Feng X; Li L; Wu J; Zhang L; Sun Z; Li X; Wang X; Yu H; Chang Y; Wu X; Zhou Z; Wang G; Li W; Li Z; Zhang X; Zhang M
    Oncologist; 2019 Nov; 24(11):e1123-e1131. PubMed ID: 30952822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of preoperative neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in patients with gallbladder carcinoma.
    Zhang Y; Jiang C; Li J; Sun J; Qu X
    Clin Transl Oncol; 2015 Oct; 17(10):810-8. PubMed ID: 26077119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A large cohort study reveals the association of elevated peripheral blood lymphocyte-to-monocyte ratio with favorable prognosis in nasopharyngeal carcinoma.
    Li J; Jiang R; Liu WS; Liu Q; Xu M; Feng QS; Chen LZ; Bei JX; Chen MY; Zeng YX
    PLoS One; 2013; 8(12):e83069. PubMed ID: 24386144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive Value of Pretreatment Lymphocyte-to-Monocyte Ratio and Platelet-to-Lymphocyte Ratio in the Survival of Nasopharyngeal Carcinoma Patients.
    Chen Y; Sun J; Hu D; Zhang J; Xu Y; Feng H; Chen Z; Luo Y; Lou Y; Wu H
    Cancer Manag Res; 2021; 13():8767-8779. PubMed ID: 34866938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of
    Xian WJ; Feng YL; Wang Y; Yang M; Lu SN
    Br J Radiol; 2022 Jan; 95(1129):20210279. PubMed ID: 34813375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer?
    Deng M; Ma X; Liang X; Zhu C; Wang M
    Oncotarget; 2017 Jun; 8(23):37200-37207. PubMed ID: 28380461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.